[1]
Dr. Md. Adnan Hasan Masud et al. 2022. RISK STRATIFICATION AND MINIMAL RESIDUAL DISEASE AFTER INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Dec. 2022), 5341–5348. DOI:https://doi.org/10.53555/1sajqe72.